Edinburg University is the address of hopeful development for vicious women with egg trouble. In the university survey; The number of eggs in women using a combination of drugs known as ABVD due to hodgkin's lymphoma was 10 times higher than that of healthy women.
A cancer drug can be used in the treatment of infertility and positive results may be obtained Gynecology and IVF Specialist Op. Dr. Betül Görgen gave the following information about the research: "Scientists studied 14 women and 12 healthy women who had been on chemotherapy for ovarian tissue.
When the ovarian tissue of eight cancer patients treated with ABVD were examined, four to ten times more eggs were seen than those who received different chemotherapy or healthy groups of the same age group.
CANCER LIGHT EGG DEVELOPMENT TRIGGERED
Researchers found that a commonly used cancer drug triggers the development of new eggs that were previously considered impossible. With this astounding discovery, researchers have proved that reversing the biological clock is possible and that the ovaries are being tricked into thinking that they are starting to produce new eggs as in the pre-adolescence period.
Dense egg clusters in the form of cluster were observed in mature women. In normal life, as women get older, both the quality of the eggs is damaged and the number is exhausted.
10 Times increase in EGGS
But scientists realize that the number of eggs in women using a combination of drugs known as ABVD for Hodgkin's lymphoma is 10 times higher than for healthy women. The shocking effect of chemotherapy on the ovaries can trigger the ovarian stem cells, thus creating new follicles.
TREATMENT CAN CAUSE STORM CELLS
The resulting effect appears to be probably the result of stimulation of the root or germ cells, but the exact underlying mechanism must be uncovered. Severe stimulation of treatment can be a shock effect, warning the root cells. This effect is really important, and although it is small, it is very important to monitor all women who are taking this treatment. The results are particularly promising for the future. Studies in the forthcoming period will address the individual and combined effects of Adriamycin, Bleomycin, Vinblastin and Dakarbasin, which form the ABVD combination, as well as the underlying biological mechanism. "